Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Los Angeles CA, Chicago IL, Louisville KY, Maumee OH,
Sponsor: Nimbus Wadjet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06898450
Phase 1, Phase 2, Recruiting
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 18+
Code: NCT06067295
Recruiting
Access to Genetic Testing in Underserved Patients With Cancer
for
Breast Carcinoma, Male Breast Carcinoma,
Location: Los Angeles CA, Rochester NY
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06422455
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Los Angeles CA, Orange CA, Aurora CO, Spokane WA,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06476808
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Los Angeles CA, Orange CA, San Diego CA, Tucson AZ,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for
Cholangiocarcinoma
Location: Los Angeles CA, Houston TX, Milwaukee WI, Chicago IL,
Sponsor: Genfit
Sex: All
Age: 18+
Code: NCT05874414
Phase 1, Phase 2, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Los Angeles CA, Santa Monica CA, La Jolla CA, Tucson AZ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, La Jolla CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase 1, Phase 2, Recruiting
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Los Angeles CA, Houston TX, Pittsburgh PA, Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05019716
Phase 1, Phase 2, Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Los Angeles CA, Oklahoma City OK, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase 2, Recruiting
Molecular Genetics Studies of Cancer Patients and Their Relatives
for
Malignant Neoplasm
Location: Los Angeles CA, Duarte CA, Fullerton CA, Orange CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 0+
Code: NCT04185935
Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Los Alamitos CA, Irving TX, Houston TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06589596
Phase 1, Recruiting
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06297265
Recruiting
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Los Angeles CA, Houston TX, Madison WI, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT05691465
Phase 2, Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Los Angeles CA, San Francisco CA, Sacramento CA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase 1, Recruiting
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
for
Clonal Cytopenia of Undetermined Significance,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06063486
Phase 2, Recruiting
Breast Cancer Survivorship Biorepository
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT05786664
Recruiting
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Solid Tumor
Location: Los Angeles CA, Duarte CA, Houston TX, Ann Arbor MI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05981703
Phase 1, Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors